Evidence map›Paper›PMID 26871455›Full record

ArticlePloS one2016

Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis.

Paul J S Skipp, Chris Hughes, Thérèse McKenna, Richard Edwards, James Langridge, Nicholas R Thomson, Ian N Clarke

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Frontiers in cellular and infection microbiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Metabolism and physiology of pathogenic bacterial obligate intracellular parasites.Frontiers in cellular and infection microbiology · 2024
    Review
  11. RipE expression correlates with high ATP levels inFrontiers in cellular and infection microbiology · 2024
    Article
  12. Article
  13. Microorganisms · 2023
    Review
  14. Genome organization and genomics inFrontiers in cellular and infection microbiology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul J S SkippCentre for Proteomic Research, Centre for Biological Sciences, University of Southampton, Southampton, United Kingdom.
Chris HughesWaters Corporation, Stamford Avenue, Wilmslow, United Kingdom.
Thérèse McKennaWaters Corporation, Stamford Avenue, Wilmslow, United Kingdom.
Richard EdwardsSchool of Biotechnology and Biomolecular Sciences, The University of New South Wales, Australia, and School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
James LangridgeWaters Corporation, Stamford Avenue, Wilmslow, United Kingdom.
Nicholas R ThomsonPathogen Genomics, The Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Ian N ClarkeMolecular Microbiology Group, School of Medicine, University of Southampton, Southampton, United Kingdom.

Funding

Wellcome TrustWellcome Trust 057347
6 · The paper itself

Abstract

The obligate intracellular developmental cycle of Chlamydia trachomatis presents significant challenges in defining its proteome. In this study we have applied quantitative proteomics to both the intracellular reticulate body (RB) and the extracellular elementary body (EB) from C. trachomatis. We used C. trachomatis L2 as a model chlamydial isolate for our study since it has a high infectivity:particle ratio and there is an excellent quality genome sequence. EBs and RBs (>99% pure) were quantified by chromosomal and plasmid copy number using PCR, from which the concentrations of chlamydial proteins per bacterial cell/genome were determined. RBs harvested at 15h post infection (PI) were purified by three successive rounds of gradient centrifugation. This is the earliest possible time to obtain purified RBs, free from host cell components in quantity, within the constraints of the technology. EBs were purified at 48h PI. We then used two-dimensional reverse phase UPLC to fractionate RB or EB peptides before mass spectroscopic analysis, providing absolute amount estimates of chlamydial proteins. The ability to express the data as molecules per cell gave ranking in both abundance and energy requirements for synthesis, allowing meaningful identification of rate-limiting components. The study assigned 562 proteins with high confidence and provided absolute estimates of protein concentration for 489 proteins. Interestingly, the data showed an increase in TTS capacity at 15h PI. Most of the enzymes involved in peptidoglycan biosynthesis were detected along with high levels of muramidase (in EBs) suggesting breakdown of peptidoglycan occurs in the non-dividing form of the microorganism. All the genome-encoded enzymes for glycolysis, pentose phosphate pathway and tricarboxylic acid cycle were identified and quantified; these data supported the observation that the EB is metabolically active. The availability of detailed, accurate quantitative proteomic data will be invaluable for investigations into gene regulation and function.

Indexed as

AnimalsBacterial ProteinsCell LineChlamydia trachomatisChlorocebus aethiopsEnergy MetabolismGenome, BacterialProteomeProteomicsBacterial ProteinsProteome

Identifiers

PMID26871455
PMCPMC4752267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.